chr12-132626188-G-A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_006231.4(POLE):c.6460C>T(p.Pro2154Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000123 in 1,461,208 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P2154R) has been classified as Uncertain significance.
Frequency
Consequence
NM_006231.4 missense
Scores
Clinical Significance
Conservation
Publications
- POLE-related polyposis and colorectal cancer syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- colorectal cancer, susceptibility to, 12Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
- facial dysmorphism-immunodeficiency-livedo-short stature syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiencyInheritance: AR Classification: STRONG Submitted by: G2P
- IMAGe syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Polymerase proofreading-related adenomatous polyposisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| POLE | NM_006231.4 | c.6460C>T | p.Pro2154Ser | missense_variant | Exon 46 of 49 | ENST00000320574.10 | NP_006222.2 | |
| POLE | XM_011534795.4 | c.6460C>T | p.Pro2154Ser | missense_variant | Exon 46 of 48 | XP_011533097.1 | ||
| POLE | XM_011534797.4 | c.5539C>T | p.Pro1847Ser | missense_variant | Exon 38 of 40 | XP_011533099.1 | ||
| POLE | XM_011534802.4 | c.3448C>T | p.Pro1150Ser | missense_variant | Exon 22 of 24 | XP_011533104.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD2 exomes  AF:  0.00000800  AC: 2AN: 249988 AF XY:  0.00000739   show subpopulations 
GnomAD4 exome  AF:  0.0000123  AC: 18AN: 1461208Hom.:  0  Cov.: 32 AF XY:  0.00000963  AC XY: 7AN XY: 726864 show subpopulations 
Age Distribution
GnomAD4 genome  
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 2154 of the POLE protein (p.Pro2154Ser). This variant is present in population databases (rs778456846, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with POLE-related conditions. ClinVar contains an entry for this variant (Variation ID: 574369). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt POLE protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Hereditary cancer-predisposing syndrome    Uncertain:1 
The p.P2154S variant (also known as c.6460C>T), located in coding exon 46 of the POLE gene, results from a C to T substitution at nucleotide position 6460. The proline at codon 2154 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Colorectal cancer, susceptibility to, 12;C3554576:Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;C5193036:Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiency    Uncertain:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at